HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lian-Jing Cao Selected Research

Colonic Neoplasms (Colon Cancer)

7/2021Polymorphisms in TYMS for Prediction of Capecitabine-Induced Hand-Foot Syndrome in Chinese Patients with Colorectal Cancer.
1/2021Glycogenes in Oncofetal Chondroitin Sulfate Biosynthesis are Differently Expressed and Correlated With Immune Response in Placenta and Colorectal Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lian-Jing Cao Research Topics

Disease

4Neoplasms (Cancer)
01/2023 - 01/2021
2Colonic Neoplasms (Colon Cancer)
07/2021 - 01/2021
2Colorectal Neoplasms (Colorectal Cancer)
07/2021 - 01/2021
1Carcinogenesis
01/2023
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2022
1Hand-Foot Syndrome
07/2021
1Malaria
01/2021
1Chronic Obstructive Pulmonary Disease (COPD)
01/2021
1Adenocarcinoma
01/2021

Drug/Important Bio-Agent (IBA)

2ChondroitinIBA
01/2023 - 01/2021
2Proteins (Proteins, Gene)FDA Link
01/2023 - 03/2021
2Chondroitin Sulfates (Chondroitin Sulfate)IBA
01/2023 - 01/2021
2Biomarkers (Surrogate Marker)IBA
01/2023 - 01/2021
2Proteoglycans (Proteoglycan)IBA
01/2023 - 01/2021
1Cell-Free Nucleic AcidsIBA
01/2023
1CarcinogensIBA
01/2023
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2023
1Fluorouracil (Carac)FDA LinkGeneric
07/2021
1ProdrugsIBA
07/2021
1Capecitabine (Xeloda)FDA Link
07/2021
1chondroitin synthaseIBA
01/2021
1SulfotransferasesIBA
01/2021
1Plasmodium falciparum VAR2CSA proteinIBA
01/2021
1Racemases and Epimerases (Epimerases and Racemases)IBA
01/2021
1EnzymesIBA
01/2021

Therapy/Procedure

1Adjuvant Chemotherapy
09/2022
1Therapeutics
03/2021
1Immunotherapy
01/2021